348 related articles for article (PubMed ID: 16731911)
21. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
Yoo LI; Mooney M; Puglielli MT; Speck SH
J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570
[TBL] [Abstract][Full Text] [Related]
22. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
23. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
J Gen Virol; 2009 May; 90(Pt 5):1183-1189. PubMed ID: 19264589
[TBL] [Abstract][Full Text] [Related]
24. Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus.
Lu F; Wiedmer A; Martin KA; Wickramasinghe PJMS; Kossenkov AV; Lieberman PM
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794029
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
[TBL] [Abstract][Full Text] [Related]
26. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
27. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
28. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
Wille CK; Li Y; Rui L; Johannsen EC; Kenney SC
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003489
[TBL] [Abstract][Full Text] [Related]
29. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
[TBL] [Abstract][Full Text] [Related]
30. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
[TBL] [Abstract][Full Text] [Related]
32. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB
J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863
[TBL] [Abstract][Full Text] [Related]
34. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
Bourillot PY; Waltzer L; Sergeant A; Manet E
J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
[TBL] [Abstract][Full Text] [Related]
36. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Puglielli MT; Woisetschlaeger M; Speck SH
J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
[TBL] [Abstract][Full Text] [Related]
37. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
Boreström C; Forsman A; Rüetschi U; Rymo L
J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
[TBL] [Abstract][Full Text] [Related]
38. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.
Gordadze AV; Peng R; Tan J; Liu G; Sutton R; Kempkes B; Bornkamm GW; Ling PD
J Virol; 2001 Jul; 75(13):5899-912. PubMed ID: 11390591
[TBL] [Abstract][Full Text] [Related]
39. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
Radkov SA; Bain M; Farrell PJ; West M; Rowe M; Allday MJ
J Virol; 1997 Nov; 71(11):8552-62. PubMed ID: 9343213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]